Jin Qunyan, Ding Wei, Mulder Kathleen M
Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.
J Biol Chem. 2007 Jun 29;282(26):19122-32. doi: 10.1074/jbc.M609915200. Epub 2007 Apr 9.
We have identified km23-1 as a novel transforming growth factor-beta (TGFbeta) receptor (TbetaR)-interacting protein that is also a light chain of the motor protein dynein (dynein light chain). Herein, we demonstrate by sucrose gradient analyses that, in the presence of TGFbeta but not in the absence, km23-1 was present in early endosomes with the TbetaRs. Further, confocal microscopy studies indicate that endogenous km23-1 was co-localized with endogenous Smad2 at early times after TGFbeta treatment, prior to Smad2 translocation to the nucleus. In addition, immunoprecipitation/blot analyses showed that TGFbeta regulated the interaction between endogenous km23-1 and endogenous Smad2 in vivo. Blockade of km23-1 using a small interfering RNA approach resulted in a reduction in both total intracellular Smad2 levels and in nuclear levels of phosphorylated Smad2 after TGFbeta treatment. This decrease was reversed by lactacystin, a specific inhibitor of the 26 S proteasome, suggesting that knockdown of km23-1 causes proteasomal degradation of phosphorylated (i.e. activated) Smad2. Blockade of km23-1 also resulted in a reduction in TGFbeta/Smad2-dependent ARE-Lux transcriptional activity, which was rescued by a km23-1 small interfering RNA-resistant construct. In contrast, a reduction in TGFbeta/Smad3-dependent SBE2-Luc transcriptional activity did not occur under similar conditions. Furthermore, overexpression of the dynactin subunit dynamitin, which is known to disrupt dynein-mediated intracellular transport, blocked TGFbeta-stimulated nuclear translocation of Smad2. Collectively, our findings indicate for the first time that a dynein light chain is required for a Smad2-dependent TGFbeta signaling pathway.
我们已确定km23-1是一种新型的转化生长因子-β(TGFβ)受体(TβR)相互作用蛋白,它也是动力蛋白轻链(动力蛋白轻链)。在此,我们通过蔗糖梯度分析证明,在有TGFβ存在而非无TGFβ时,km23-1与TβR一起存在于早期内体中。此外,共聚焦显微镜研究表明,内源性km23-1在TGFβ处理后的早期与内源性Smad2共定位,早于Smad2易位至细胞核。另外,免疫沉淀/印迹分析显示,TGFβ在体内调节内源性km23-1与内源性Smad2之间的相互作用。使用小干扰RNA方法阻断km23-1会导致TGFβ处理后细胞内Smad2总水平和磷酸化Smad2核水平均降低。26S蛋白酶体的特异性抑制剂乳胞素可逆转这种降低,这表明敲低km23-1会导致磷酸化(即活化的)Smad2的蛋白酶体降解。阻断km23-1还会导致TGFβ/Smad2依赖性ARE-Lux转录活性降低,而一种对km23-1小干扰RNA有抗性的构建体可挽救这种降低。相反,在类似条件下,TGFβ/Smad3依赖性SBE2-Luc转录活性并未降低。此外,已知可破坏动力蛋白介导的细胞内运输的动力蛋白激活蛋白亚基动力蛋白的过表达会阻断TGFβ刺激的Smad2核易位。总体而言,我们的研究结果首次表明,动力蛋白轻链是Smad2依赖性TGFβ信号通路所必需的。